Rounds

NIH funds $5.6 million center for PKD research

A five-year, $5.6 million grant awarded by the National Institutes of Health has established Yale as one of four centers of excellence for the study of a kidney disorder that is the nation’s most common life-threatening genetic disease. The new center brings together investigators from several departments to focus on polycystic kidney disease (PKD). Plans also are in the works to add a clinical component to speed translation of research discoveries into treatment advances.

Although not all people with the disease are aware of the diagnosis, PKD is believed to affect some 600,000 Americans. The inherited disorder causes cysts to develop in the kidneys, interfering in their normal functioning and frequently resulting in the need for dialysis or transplantation. There is no treatment or cure for the disease, which results in about 1,000 deaths each year due to kidney failure. According to...

Read more...

Mental illness a barrier to cardiac care

In a first-ever study of the role mental illness plays in cardiovascular care, a team of Yale psychiatric and public health experts found that mentally ill patients receive significantly fewer cardiovascular procedures following a heart attack than other patients. Previous studies have shown that race and gender are important factors in the treatment of cardiovascular patients, but this is the first study to show...

Read more...

Anti-cocaine vaccine passes first hurdle

Most of the 900,000 cocaine abusers who seek treatment for their addiction each year in the United States eventually...

Read more...

Stress worsens arrhythmias, increasing risk of sudden death

Stress is as much a part of daily life as traffic jams and taxes. For those susceptible to arrhythmia, an abnormal...

Read more...

Rate of tick-borne disease higher than suspected

Ehrlichiosis, a disease carried by the same tick that transmits Lyme disease, is occurring at much higher rates than...

Read more...


Conventional Lyme treatment found effective

Patients who undergo conventional antimicrobial treatment for Lyme disease report no greater level of health problems...

Read more...


 
Download on the Apple App Store